OBJECTIVES: Neurofunctional alterations are correlates of vulnerability to psychosis, as well as of the disorder itself. How these abnormalities relate to different probabilities for later transition to psychosis is unclear. We investigated vulnerability- versus disease-related versus resilience biomarkers of psychosis during working memory (WM) processing in individuals with an at-risk mental state (ARMS). EXPERIMENTAL DESIGN: Patients with "first-episode psychosis" (FEP, n = 21), short-term ARMS (ARMS-ST, n = 17), long-term ARMS (ARMS-LT, n = 16), and healthy controls (HC, n = 20) were investigated with an n-back WM task. We examined functional magnetic resonance imaging (fMRI) and structural magnetic resonance imaging (sMRI) data in conjunction using biological parametric mapping (BPM) toolbox. PRINCIPAL OBSERVATIONS: There were no differences in accuracy, but the FEP and the ARMS-ST group had longer reaction times compared with the HC and the ARMS-LT group. With the 2-back > 0-back contrast, we found reduced functional activation in ARMS-ST and FEP compared with the HC group in parietal and middle frontal regions. Relative to ARMS-LT individuals, FEP patients showed decreased activation in the bilateral inferior frontal gyrus and insula, and in the left prefrontal cortex. Compared with the ARMS-LT, the ARMS-ST subjects showed reduced activation in the right inferior frontal gyrus and insula. Reduced insular and prefrontal activation was associated with gray matter volume reduction in the same area in the ARMS-LT group. CONCLUSIONS: These findings suggest that vulnerability to psychosis was associated with neurofunctional alterations in fronto-temporo-parietal networks in a WM task. Neurofunctional differences within the ARMS were related to different duration of the prodromal state and resilience factors.
OBJECTIVES: Neurofunctional alterations are correlates of vulnerability to psychosis, as well as of the disorder itself. How these abnormalities relate to different probabilities for later transition to psychosis is unclear. We investigated vulnerability- versus disease-related versus resilience biomarkers of psychosis during working memory (WM) processing in individuals with an at-risk mental state (ARMS). EXPERIMENTAL DESIGN:Patients with "first-episode psychosis" (FEP, n = 21), short-term ARMS (ARMS-ST, n = 17), long-term ARMS (ARMS-LT, n = 16), and healthy controls (HC, n = 20) were investigated with an n-back WM task. We examined functional magnetic resonance imaging (fMRI) and structural magnetic resonance imaging (sMRI) data in conjunction using biological parametric mapping (BPM) toolbox. PRINCIPAL OBSERVATIONS: There were no differences in accuracy, but the FEP and the ARMS-ST group had longer reaction times compared with the HC and the ARMS-LT group. With the 2-back > 0-back contrast, we found reduced functional activation in ARMS-ST and FEP compared with the HC group in parietal and middle frontal regions. Relative to ARMS-LT individuals, FEP patients showed decreased activation in the bilateral inferior frontal gyrus and insula, and in the left prefrontal cortex. Compared with the ARMS-LT, the ARMS-ST subjects showed reduced activation in the right inferior frontal gyrus and insula. Reduced insular and prefrontal activation was associated with gray matter volume reduction in the same area in the ARMS-LT group. CONCLUSIONS: These findings suggest that vulnerability to psychosis was associated with neurofunctional alterations in fronto-temporo-parietal networks in a WM task. Neurofunctional differences within the ARMS were related to different duration of the prodromal state and resilience factors.
Authors: P Fusar-Poli; M R Broome; J B Woolley; L C Johns; P Tabraham; E Bramon; L Valmaggia; S C Williams; P McGuire Journal: J Psychiatr Res Date: 2010-06-30 Impact factor: 4.791
Authors: P Fusar-Poli; S Borgwardt; A Crescini; G Deste; Matthew J Kempton; S Lawrie; P Mc Guire; E Sacchetti Journal: Neurosci Biobehav Rev Date: 2010-12-17 Impact factor: 8.989
Authors: Ramon Casanova; Ryali Srikanth; Aaron Baer; Paul J Laurienti; Jonathan H Burdette; Satoru Hayasaka; Lynn Flowers; Frank Wood; Joseph A Maldjian Journal: Neuroimage Date: 2006-10-27 Impact factor: 6.556
Authors: R Smieskova; P Fusar-Poli; P Allen; K Bendfeldt; R D Stieglitz; J Drewe; E W Radue; P K McGuire; A Riecher-Rössler; S J Borgwardt Journal: Curr Pharm Des Date: 2009 Impact factor: 3.116
Authors: D S Manoach; D Z Press; V Thangaraj; M M Searl; D C Goff; E Halpern; C B Saper; S Warach Journal: Biol Psychiatry Date: 1999-05-01 Impact factor: 13.382
Authors: David C Glahn; J Daniel Ragland; Adir Abramoff; Jennifer Barrett; Angela R Laird; Carrie E Bearden; Dawn I Velligan Journal: Hum Brain Mapp Date: 2005-05 Impact factor: 5.038
Authors: S J Borgwardt; E-W Radue; K Götz; J Aston; M Drewe; U Gschwandtner; S Haller; M Pflüger; R-D Stieglitz; P K McGuire; A Riecher-Rössler Journal: J Neurol Neurosurg Psychiatry Date: 2006-02 Impact factor: 10.154
Authors: Joseph H Callicott; Michael F Egan; Venkata S Mattay; Alessandro Bertolino; Ashley D Bone; Beth Verchinksi; Daniel R Weinberger Journal: Am J Psychiatry Date: 2003-04 Impact factor: 18.112
Authors: Henning Witthaus; Christian Kaufmann; Georg Bohner; Seza Ozgürdal; Yehonala Gudlowski; Jürgen Gallinat; Stephan Ruhrmann; Martin Brüne; Andreas Heinz; Randolf Klingebiel; Georg Juckel Journal: Psychiatry Res Date: 2009-07-17 Impact factor: 3.222
Authors: Dennis Velakoulis; Stephen J Wood; Michael T H Wong; Patrick D McGorry; Alison Yung; Lisa Phillips; De Smith; Warrick Brewer; Tina Proffitt; Patricia Desmond; Christos Pantelis Journal: Arch Gen Psychiatry Date: 2006-02
Authors: André Schmidt; Renata Smieskova; Andor Simon; Paul Allen; Paolo Fusar-Poli; Philip K McGuire; Kerstin Bendfeldt; Jacqueline Aston; Undine E Lang; Marc Walter; Ernst-Wilhelm Radue; Anita Riecher-Rössler; Stefan J Borgwardt Journal: J Psychiatry Neurosci Date: 2014-07 Impact factor: 6.186
Authors: Heidi W Thermenos; Richard J Juelich; Samantha R DiChiara; Raquelle I Mesholam-Gately; Kristen A Woodberry; Joanne Wojcik; Nikos Makris; Matcheri S Keshavan; Susan Whitfield-Gabrieli; Tsung-Ung W Woo; Tracey L Petryshen; Jill M Goldstein; Martha E Shenton; Robert W McCarley; Larry J Seidman Journal: Schizophr Res Date: 2016-03-07 Impact factor: 4.939
Authors: Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger Journal: Nat Rev Drug Discov Date: 2016-03-04 Impact factor: 84.694
Authors: Dylan G Gee; Katherine H Karlsgodt; Theo G M van Erp; Carrie E Bearden; Matthew D Lieberman; Aysenil Belger; Diana O Perkins; Doreen M Olvet; Barbara A Cornblatt; Todd Constable; Scott W Woods; Jean Addington; Kristin S Cadenhead; Thomas H McGlashan; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Tyrone D Cannon Journal: Schizophr Res Date: 2011-11-06 Impact factor: 4.939
Authors: Paul Klauser; Juan Zhou; Joseph K W Lim; Joann S Poh; Hui Zheng; Han Ying Tng; Ranga Krishnan; Jimmy Lee; Richard S E Keefe; R Alison Adcock; Stephen J Wood; Alex Fornito; Michael W L Chee Journal: Schizophr Bull Date: 2015-03-04 Impact factor: 9.306
Authors: William Pettersson-Yeo; Stefania Benetti; Silvia Frisciata; Marco Catani; Steve C R Williams; Paul Allen; Philip McGuire; Andrea Mechelli Journal: J Psychiatry Neurosci Date: 2015-03 Impact factor: 6.186
Authors: Nenad Vasic; Nadine D Wolf; Georg Grön; Zrinka Sosic-Vasic; Bernhard J Connemann; Fabio Sambataro; Anna von Strombeck; Dirk Lang; Stefanie Otte; Manuela Dudek; Robert C Wolf Journal: J Psychiatry Neurosci Date: 2015-11 Impact factor: 6.186